- Insurance denial does not mean you are out of options. Five proven paths exist to access GLP-1 medications without coverage.
- Compounded semaglutide from licensed 503B pharmacies starts at $199/mo, compared to $1,349/mo retail for brand-name Wegovy.
- Manufacturer savings programs can bring costs down significantly for people with commercial insurance that does not cover weight loss drugs.
- HSA and FSA accounts can reduce your effective out-of-pocket cost by 20 to 40 percent on a pre-tax basis.
- Insurance denials are frequently reversed on appeal, especially with strong medical documentation and a letter of necessity from your provider.
If your insurance won't cover GLP-1 medication, you are not stuck. Millions of Americans access semaglutide and tirzepatide every month without insurance. This guide walks through every legitimate option, what each one costs, and exactly how to use it.
Ozempic, Wegovy, Zepbound, and Mounjaro are among the most effective medications ever developed for weight loss. Clinical trials show average body weight reductions of 15 to 22.5 percent. And yet, getting insurance to pay for them is one of the most frustrating experiences in modern healthcare.
If you have already hit a wall with your insurer, or if you suspect coverage is not coming, this is the guide you need. We will cover every realistic option, including the one that most people start with.
Why insurance rarely covers GLP-1 for weight loss
Insurance companies have three primary reasons for denying GLP-1 coverage, and understanding them helps you respond strategically.
The "cosmetic treatment" classification
Despite overwhelming clinical evidence that obesity is a chronic disease with serious cardiovascular, metabolic, and orthopedic consequences, many insurance plans still classify weight loss treatment as cosmetic or elective. This determination is made at the plan level, not by your doctor, and it can apply even when you have documented comorbidities.
Prior authorization requirements
Plans that do cover GLP-1 medications typically require prior authorization before they will pay. This means your provider must submit documentation showing that you meet specific criteria, such as a BMI over 30, or over 27 with a qualifying comorbidity, and that you have tried and failed other weight loss interventions. The process can take weeks, and initial denials are common even when criteria are met.
Formulary exclusions
Many employer-sponsored health plans simply do not include GLP-1 weight loss medications on their formulary at all. This is a plan-level decision driven by cost. Wegovy and Zepbound retail for over $1,300 per month, and employers covering these drugs for large workforces face significant cost increases. As of 2025, fewer than half of employer plans covered GLP-1 medications for weight management.
5 proven paths to affordable GLP-1
Compounded semaglutide or tirzepatide
$199 to $500/moCompounded GLP-1 medications are produced by FDA-registered 503A and 503B pharmacies using pharmaceutical-grade active ingredients. The compound contains the same active molecule as Wegovy or Zepbound, at a fraction of the brand-name price.
This is the most widely used option for people paying out of pocket, and for good reason. The cost difference is dramatic. Compounded semaglutide starts at around $199 per month for starter doses, compared to $1,349 for brand-name Wegovy. Compounded tirzepatide is similarly priced.
To access compounded GLP-1, you need a prescription from a licensed US provider. Telehealth platforms like Kind MD handle the full process online: intake, provider review, prescription, and pharmacy fulfillment, with the medication shipped directly to your door.
What to look for: Always confirm your provider sources from a licensed 503A or 503B pharmacy and that the compound is semaglutide base (not semaglutide sodium or semaglutide acetate, which are not equivalent).
Manufacturer savings programs
$0 to $200/mo (with commercial insurance)Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) both offer savings card programs that can significantly reduce out-of-pocket costs. The key nuance is that these programs are generally available to people with commercial insurance, including plans that cover the drug but require a high copay.
The Wegovy savings card has historically allowed eligible patients to pay as little as $0 per month for up to 13 fills, though eligibility rules and maximum savings caps change periodically. Eli Lilly's Zepbound savings program operates similarly.
Important limitation: These programs are not available to Medicare, Medicaid, or uninsured patients in most cases. If your plan excludes GLP-1 medications from the formulary entirely, savings cards typically will not apply. Always verify current eligibility at the manufacturer's official website before assuming you qualify.
HSA and FSA funds
20 to 40% effective discount on your out-of-pocket costIf you have a Health Savings Account (HSA) or Flexible Spending Account (FSA), you can use those pre-tax dollars to pay for prescription GLP-1 medications, including compounded versions, as long as you have a valid prescription from a licensed provider.
The savings are real. If you are in the 22 percent federal tax bracket, using HSA or FSA funds on a $300/mo prescription effectively costs you around $234 after the tax advantage. Depending on your state income tax rate and total bracket, the discount can reach 30 to 40 percent.
HSA funds roll over indefinitely, making them an especially efficient vehicle for ongoing prescription costs. FSA funds typically have a use-it-or-lose-it structure, so plan your spending accordingly.
Canadian and international pharmacies
$300 to $700/mo (brand-name Ozempic)Brand-name semaglutide (marketed as Ozempic in Canada) is available at significantly lower prices through licensed Canadian pharmacies. Many Americans have used this route to access GLP-1 medication, and some telehealth providers operate formal cross-border prescription services.
Legal caveats: The FDA technically prohibits importing prescription medications for personal use, though enforcement against individual consumers has been minimal historically. Ordering from an unverified international source carries real risks: counterfeit products, inconsistent potency, and no quality controls. If you pursue this route, use only pharmacies verified by the Canadian International Pharmacy Association (CIPA) or PharmacyChecker, and always have a valid prescription from a US licensed provider.
This option is best treated as a stopgap for people already on a stable brand-name dose who cannot afford US retail pricing, not as a starting point.
Appeal your insurance denial
$0 if successful (worth attempting before any other option)Insurance denials are not final. The appeal process is formal, but it works. Studies have found that roughly 40 percent of insurance denials are reversed on the first internal appeal when properly documented. If your insurer denies your internal appeal, you have the right to an independent external review.
The appeal process takes time (typically 30 to 60 days for standard appeals, shorter for expedited urgent appeals), but if your insurer does cover GLP-1 medication in any form, winning an appeal means you pay only your normal cost-sharing. The potential savings over a year or more of treatment make the effort worthwhile.
See the full appeal guide below for step-by-step instructions.
Cost comparison: all 5 options side by side
| Option | Monthly Cost | Legitimacy | How to Access | Best For |
|---|---|---|---|---|
| Compounded semaglutide / tirzepatide | $199 to $500 | Legal with prescription; 503B pharmacy required | Licensed telehealth provider (e.g., Kind MD) | Most people without coverage; fastest start |
| Manufacturer savings programs | $0 to $200 | Fully legal; manufacturer-sponsored | Wegovy.com or Zepbound.lilly.com with commercial insurance | People with commercial insurance and high copay |
| HSA / FSA | Your cost minus 20 to 40% | Fully legal with valid prescription | Use existing HSA/FSA card at pharmacy or telehealth checkout | Anyone with an HSA or FSA account |
| Canadian / international pharmacy | $300 to $700 | Legal gray area; use CIPA-verified pharmacies only | CIPA or PharmacyChecker-listed pharmacy with US prescription | People on stable brand-name dose, price-shopping |
| Insurance appeal | $0 if successful | Fully legal; patient right under ACA | Submit formal appeal with medical documentation | Anyone with an insurance denial worth fighting |
Kind MD offers transparent cash pricing for compounded semaglutide and tirzepatide, starting at $199/mo.
Licensed US providers. 503B pharmacy. Ships nationwide. No surprise fees.
Check My Eligibility →How to appeal your insurance denial
An insurance denial comes with an Explanation of Benefits (EOB) and a denial letter. Both documents contain the specific reason for denial and information about your right to appeal. Start there.
The step-by-step process
- Understand why you were denied. The denial letter will list a reason code. Common ones include "not medically necessary," "cosmetic treatment," "formulary exclusion," or "prior authorization required." Each reason requires a different appeal strategy.
- Request a complete copy of your plan's coverage criteria. Call member services and ask for the clinical coverage guidelines for weight management medications. These are the exact standards your provider needs to document against.
- Get a letter of medical necessity from your provider. This letter should include your diagnosis codes (E66.01 for morbid obesity, E11 for type 2 diabetes, I10 for hypertension, etc.), your BMI, any comorbidities, and a clinical rationale for why GLP-1 medication is medically necessary in your case. Reference the STEP and SURMOUNT-1 clinical trial data.
- Document prior treatment attempts. Your plan may require evidence that you tried other weight loss interventions first. Compile any records of supervised diet programs, behavioral counseling, or other medications you have used.
- Submit your internal appeal in writing. Include your letter of medical necessity, diagnosis codes, relevant lab work (A1C, lipid panel, blood pressure records), and a written appeal letter referencing the clinical evidence. Send via certified mail and keep copies of everything.
- If denied again, request an external review. Under the Affordable Care Act, you have the right to an independent external review of any denial. An independent organization, not your insurer, makes the determination. External reviews overturn internal denials in a meaningful percentage of cases.
Patient name, member ID, claim number, and the specific drug being requested. Your diagnosis (ICD-10 codes). Your BMI and any comorbidities. A statement that GLP-1 medication is medically necessary per the clinical evidence (cite STEP 1 trial for semaglutide, SURMOUNT-1 for tirzepatide). Documentation of prior weight loss attempts. A request that the denial be overturned and coverage approved. Your provider's signature and NPI number.
Most commercial insurers have an internal appeals process that runs 30 to 60 days for standard appeals, and 72 hours for expedited urgent appeals. Use the expedited process only if your provider documents that a delay would seriously jeopardize your health.
Red flags to avoid
Not every source offering GLP-1 at a low price is legitimate. The stakes are high: counterfeit or contaminated injectables carry serious health risks. These are the warning signs to watch for.
- Research peptides marketed for weight loss. Sites selling "research-grade" semaglutide or tirzepatide are not selling pharmaceutical products. These compounds are not produced under pharmaceutical manufacturing standards and are not intended for human use. The active ingredient may be mislabeled, underdosed, or contaminated.
- No prescription required. Any US-based provider offering GLP-1 medication without a consultation and valid prescription is operating illegally. A prescription requirement is a patient safety protection, not a bureaucratic hurdle.
- Unverified international pharmacies. Ordering from a random overseas website is not the same as using a CIPA-verified Canadian pharmacy. Counterfeit Ozempic has been documented by the FDA. Stick to verified sources.
- Semaglutide sodium or semaglutide acetate compounds. These salt forms of semaglutide have not been demonstrated to have the same efficacy as semaglutide base. The FDA has raised concerns about them. Ask your provider explicitly which form is being dispensed.
- No follow-up care or dose titration support. GLP-1 medication requires dose escalation over several months. Providers who dispense a single dose with no follow-up are not practicing responsible medicine. You need ongoing monitoring.
The FDA has issued multiple warnings about counterfeit semaglutide products. Always verify that your provider is licensed in your state and that your medication ships from a US-registered 503A or 503B pharmacy. If something about a supplier's pricing or process seems off, trust that instinct.
Kind MD's transparent cash pricing
Kind MD was built for patients who are paying out of pocket. Our model is simple: no hidden fees, no upsells, no bait-and-switch pricing. You know exactly what you are paying before you start.
Here is what your Kind MD subscription includes:
- Async provider consultation and eligibility review
- Prescription from a licensed US provider in your state
- Compounded semaglutide or tirzepatide from an FDA-registered 503B pharmacy
- Medication shipped directly to your door
- Ongoing check-ins and dose escalation support
- Provider availability for questions throughout treatment
Starter doses begin at $199 per month. Pricing scales with your maintenance dose, which most patients reach after the first three to four months of treatment. We accept HSA and FSA cards and provide documentation you can use for insurance reimbursement requests.
We built Kind MD because we believe access to effective weight loss treatment should not depend on what insurance your employer chose.